Applied Biologics Announces Acceptance of XWRAP® Translational Research for Presentation at SAWC Fall 2026
Applied Biologics announced that its translational research on XWRAP placental tissue allografts has been accepted for presentation at the SAWC Fall 2026 conference. The study demonstrates the efficacy of the company's proprietary processing in improving wound-healing outcomes.
Why it matters
Advancements in regenerative medicine and tissue engineering are critical for addressing chronic wound care, a significant unmet medical need.
Research evaluating the influence of placental tissue processing on wound-healing biology accepted for presentation at leading wound care scientific meeting
SCOTTSDALE, Ariz., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel therapies for serious diseases with significant unmet medical needs, today announced that new translational research involving XWRAP® has been accepted for presentation at the Symposium on Advanced Wound Care (SAWC) Fall 2026, taking place October 15-18, 2026, in Las Vegas, Nevada.
The accepted abstract, "Proprietary Processing of Placental Tissue Allografts Influences Wound Healing Trajectories in a Rodent Excisional Wound Model,” will be included in the SAWC Fall 2026 scientific program as both a printed poster in the Poster Hall and an electronic poster available through the conference’s digital platforms.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in